<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39188336</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Randomized Controlled Trials for Post-COVID-19 Conditions: A Systematic Review.</ArticleTitle><Pagination><StartPage>e67603</StartPage><MedlinePgn>e67603</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e67603</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.67603</ELocationID><Abstract><AbstractText>Post-coronavirus disease 2019 (COVID-19) syndrome or condition (PCS) is defined as new onset symptoms for at least three months following COVID-19 infection that has persisted for at least two months. Given the global sequelae of COVID-19, there is an urgent need for effective PCS interventions. The aim of this study was to systematically review all interventions for PCS tested in randomized controlled trials.&#xa0;In this International Prospective Register of Systematic Reviews (PROSPERO) registered (CRD42023415835) systematic review, PubMed, Google Scholar, and ClinicalTrials.gov databases were searched between 1st January 2020 and 30th April 2023. Inclusion criteria were (1) randomized controlled trials that tested interventions for (2) PCS as defined above. Studies were independently reviewed, and final decisions regarding extracted data and risk of bias were made by consensus. Trial findings were summarized qualitatively.&#xa0;The review included 23 trials with 1,916 subjects (mean age 44.9, 25.8% males) from 10 countries. The predominant symptom or function targeted by the interventions were general long COVID-19 symptoms (35%), fatigue (30%), breathlessness (17%), olfactory (17%), and brain function (9%). Overall, the majority of trials (74%) were at high risk of bias. A range of interventions were identified, including physical therapies, dietary and regenerative treatments, electrical stimulation, and digital wellness programs with variable effects.&#xa0;While a diverse range of interventions for PCS have been tested, their effectiveness varies, with threats to validity in most studies. Trials focusing on PCS mental health disorders, musculoskeletal complaints, and children are needed. Well-designed RCTs are needed to establish definitive interventions for PCS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Motilal et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Motilal</LastName><ForeName>Shastri</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Paraclinical Sciences Department, The University of the West Indies, St. Augustine Campus, Faculty of Medical Sciences, St. Augustine, TTO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rampersad</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Paraclinical Sciences Department, The University of the West Indies, St. Augustine Campus, Faculty of Medical Sciences, St. Augustine, TTO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>Merc&#xe9;des</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Paraclinical Sciences Department, The University of the West Indies, St. Augustine Campus, Faculty of Medical Sciences, St. Augustine, TTO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goon Lun</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Paraclinical Sciences Department, The University of the West Indies, St. Augustine Campus, Faculty of Medical Sciences, St. Augustine, TTO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramdhanie</LastName><ForeName>Adesh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Paraclinical Sciences Department, The University of the West Indies, St. Augustine Campus, Faculty of Medical Sciences, St. Augustine, TTO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Tricia</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Paraclinical Sciences Department, The University of the West Indies, St. Augustine Campus, Faculty of Medical Sciences, St. Augustine, TTO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Amresh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Paraclinical Sciences Department, The University of the West Indies, St. Augustine Campus, Faculty of Medical Sciences, St. Augustine, TTO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkinson</LastName><ForeName>Arien</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Paraclinical Sciences Department, The University of the West Indies, St. Augustine Campus, Faculty of Medical Sciences, St. Augustine, TTO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Jadon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Paraclinical Sciences Department, The University of the West Indies, St. Augustine Campus, Faculty of Medical Sciences, St. Augustine, TTO.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of covid-19</Keyword><Keyword MajorTopicYN="N">randomized controlled trials</Keyword><Keyword MajorTopicYN="N">sars-cov-2 infection</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39188336</ArticleId><ArticleId IdType="pmc">PMC11345588</ArticleId><ArticleId IdType="doi">10.7759/cureus.67603</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aleem A, Akbar Samad AB, Slenker AK. Treasure Island (FL): StatPearls Publishing; 2022. Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)</Citation></Reference><Reference><Citation>Interventions for Improving long COVID-19 symptomatology: a systematic review. Veronese N, Bonica R, Cotugno S, et al. Viruses. 2022;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9502379</ArticleId><ArticleId IdType="pubmed">36146672</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID Basics.  [
Nov;
2022 
]. 2022. https://www.cdc.gov/covid/long-term-effects/?CDC_AAref_Val=https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html https://www.cdc.gov/covid/long-term-effects/?CDC_AAref_Val=https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html</Citation></Reference><Reference><Citation>Coronavirus disease (COVID- 19): Post COVID-19 condition.  [
Jun;
2023 
]. 2023. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition</Citation></Reference><Reference><Citation>Harzing AW. Harzing AW. Publish or Perish Software [Internet. Publish or Perish Software. https://harzing.com/resources/publish-or-perish https://harzing.com/resources/publish-or-perish</Citation></Reference><Reference><Citation>RoB 2: a revised tool for assessing risk of bias in randomised trials. Sterne JA, Savovi&#x107; J, Page MJ, et al. BMJ. 2019;366:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk of bias tools - RoB 2 for crossover trials.  [
Apr;
2023 
]. 2023. https://www.riskofbias.info/welcome/rob-2-0-tool/rob-2-for-crossover-trials https://www.riskofbias.info/welcome/rob-2-0-tool/rob-2-for-crossover-trials</Citation></Reference><Reference><Citation>Motilal S, Lewis J, Adams M, et al.  Systematic Review of trials of interventions for the post COVID-19 condition. PROSPERO.  [
Aug;
2024 
]. 2023. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023415835 https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023415835</Citation></Reference><Reference><Citation>How to properly use the PRISMA Statement. Sarkis-Onofre R, Catal&#xe1;-L&#xf3;pez F, Aromataris E, Lockwood C. Syst Rev. 2021;10:117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056687</ArticleId><ArticleId IdType="pubmed">33875004</ArticleId></ArticleIdList></Reference><Reference><Citation>Inpatient post-COVID-19 rehabilitation program featuring virtual reality-preliminary results of randomized controlled trial. Rutkowski S, Bogacz K, Rutkowska A, Szczegielniak J, Casaburi R. Front Public Health. 2023;11:1121554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9939639</ArticleId><ArticleId IdType="pubmed">36815161</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial. Bazdyrev E, Panova M, Brachs M, et al. J Transl Med. 2022;20:506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9632561</ArticleId><ArticleId IdType="pubmed">36329513</ArticleId></ArticleIdList></Reference><Reference><Citation>Possible role of ivermectin mucoadhesive nanosuspension nasal spray in recovery of post-COVID-19 anosmia. Aref ZF, Bazeed SE, Hassan MH, et al. Infect Drug Resist. 2022;15:5483&#x2013;5494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9508858</ArticleId><ArticleId IdType="pubmed">36164334</ArticleId></ArticleIdList></Reference><Reference><Citation>Fermented Carica papaya and Morinda citrifolia as perspective food supplements for the treatment of post-COVID symptoms: randomized placebo-controlled clinical laboratory study. Kharaeva Z, Shokarova A, Shomakhova Z, et al. Nutrients. 2022;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9182401</ArticleId><ArticleId IdType="pubmed">35684003</ArticleId></ArticleIdList></Reference><Reference><Citation>Influence of manual diaphragm release technique combined with inspiratory muscle training on selected persistent symptoms in men with post-Covid-19 syndrome: a randomized controlled trial. Nagy EN, Elimy DA, Ali AY, Ezzelregal HG, Elsayed MM. J Rehabil Med. 2022;54:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9608026</ArticleId><ArticleId IdType="pubmed">36121338</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy of adaptogens in patients with long COVID-19: a randomized, quadruple-blind, placebo-controlled trial. Karosanidze I, Kiladze U, Kirtadze N, et al. Pharmaceuticals (Basel) 2022;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8953947</ArticleId><ArticleId IdType="pubmed">35337143</ArticleId></ArticleIdList></Reference><Reference><Citation>A 14-day therapeutic exercise telerehabilitation protocol of physiotherapy is effective in non-hospitalized post-COVID-19 conditions: a randomized controlled trial. Rodriguez-Blanco C, Bernal-Utrera C, Anarte-Lazo E, Gonzalez-Gerez JJ, Saavedra-Hernandez M. J Clin Med. 2023;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9918076</ArticleId><ArticleId IdType="pubmed">36769425</ArticleId></ArticleIdList></Reference><Reference><Citation>Positive impacts of a four-week neuro-meditation program on cognitive function in post-acute sequelae of COVID-19 patients: a randomized controlled trial. Hausswirth C, Schmit C, Rougier Y, Coste A. Int J Environ Res Public Health. 2023;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9858974</ArticleId><ArticleId IdType="pubmed">36674117</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of ultra-micronized palmitoylethanolamide and luteolin on olfaction and memory in patients with long COVID: results of a longitudinal study. De Luca P, Camaioni A, Marra P, et al. Cells. 2022;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9406356</ArticleId><ArticleId IdType="pubmed">36010630</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial. Kjellberg A, Hassler A, Bostr&#xf6;m E, et al. BMC Infect Dis. 2023;23:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9854077</ArticleId><ArticleId IdType="pubmed">36670365</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial. Farahani RH, Ajam A, Naeini AR. BMC Infect Dis. 2023;23:197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10064948</ArticleId><ArticleId IdType="pubmed">37003990</ArticleId></ArticleIdList></Reference><Reference><Citation>A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms. Badran BW, Huffman SM, Dancy M, Austelle CW, Bikson M, Kautz SA, George MS. Res Sq. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9402278</ArticleId><ArticleId IdType="pubmed">36002874</ArticleId></ArticleIdList></Reference><Reference><Citation>Effects of l-arginine plus vitamin C supplementation on l-arginine metabolism in adults with long COVID: secondary analysis of a randomized clinical trial. Calvani R, Gervasoni J, Picca A, et al. Int J Mol Sci. 2023;24</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10049539</ArticleId><ArticleId IdType="pubmed">36982151</ArticleId></ArticleIdList></Reference><Reference><Citation>Effects of hyperbaric oxygen therapy on functional and structural connectivity in post-COVID-19 condition patients: a randomized, sham-controlled trial. Catalogna M, Sasson E, Hadanny A, Parag Y, Zilberman-Itskovich S, Efrati S. Neuroimage Clin. 2022;36:103218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9528018</ArticleId><ArticleId IdType="pubmed">36208548</ArticleId></ArticleIdList></Reference><Reference><Citation>A pilot study of short-course oral vitamin A and aerosolised diffuser olfactory training for the treatment of smell loss in long COVID. Chung TW, Zhang H, Wong FK, et al. Brain Sci. 2023;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10377650</ArticleId><ArticleId IdType="pubmed">37508945</ArticleId></ArticleIdList></Reference><Reference><Citation>Home-based respiratory muscle training on quality of life and exercise tolerance in long-term post-COVID-19: randomized controlled trial. Del Corral T, Fabero-Garrido R, Plaza-Manzano G, Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Navarro-Santana M, L&#xf3;pez-de-Uralde-Villanueva I. Ann Phys Rehabil Med. 2023;66:101709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9708524</ArticleId><ArticleId IdType="pubmed">36191860</ArticleId></ArticleIdList></Reference><Reference><Citation>Ultramicronized palmitoylethanolamide and luteolin supplement combined with olfactory training to treat post-COVID-19 olfactory impairment: a multi-center double-blinded randomized placebo- controlled clinical trial. Di Stadio A, D'Ascanio L, Vaira LA, et al. Curr Neuropharmacol. 2022;20:2001&#x2013;2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9886808</ArticleId><ArticleId IdType="pubmed">35450527</ArticleId></ArticleIdList></Reference><Reference><Citation>High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial. Hansen KS, Mogensen TH, Agergaard J, Schi&#xf8;ttz-Christensen B, &#xd8;stergaard L, Vibholm LK, Leth S. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627534/ Lancet Reg Health Eur. 2022;24:100539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9627534</ArticleId><ArticleId IdType="pubmed">36337437</ArticleId></ArticleIdList></Reference><Reference><Citation>Aromatherapy blend of thyme, orange, clove bud, and frankincense boosts energy levels in post-COVID-19 female patients: A randomized, double-blinded, placebo controlled clinical trial. Hawkins J, Hires C, Keenan L, Dunne E. Complement Ther Med. 2022;67:102823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8949693</ArticleId><ArticleId IdType="pubmed">35341944</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: a randomized controlled trial. Jimeno-Almaz&#xe1;n A, Franco-L&#xf3;pez F, Buend&#xed;a-Romero &#xc1;, et al. Scand J Med Sci Sports. 2022;32:1791&#x2013;1801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538729</ArticleId><ArticleId IdType="pubmed">36111386</ArticleId></ArticleIdList></Reference><Reference><Citation>Effects of a concurrent training, respiratory muscle exercise, and self-management recommendations on recovery from post-COVID-19 conditions: the RECOVE trial. Jimeno-Almaz&#xe1;n A, Buend&#xed;a-Romero &#xc1;, Mart&#xed;nez-Cava A, Franco-L&#xf3;pez F, S&#xe1;nchez-Alcaraz BJ, Courel-Ib&#xe1;&#xf1;ez J, Pallar&#xe9;s JG. J Appl Physiol (1985) 2023;134:95&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9829459</ArticleId><ArticleId IdType="pubmed">36476156</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy of combined visual-olfactory training with patient-preferred scents as treatment for patients with COVID-19 resultant olfactory loss: a randomized clinical trial. Khan AM, Piccirillo J, Kallogjeri D, Piccirillo JF. JAMA Otolaryngol Head Neck Surg. 2023;149:141&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9857399</ArticleId><ArticleId IdType="pubmed">36580304</ArticleId></ArticleIdList></Reference><Reference><Citation>Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. McNarry MA, Berg RM, Shelley J, et al. Eur Respir J. 2022;60</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8900538</ArticleId><ArticleId IdType="pubmed">35236727</ArticleId></ArticleIdList></Reference><Reference><Citation>Water-based and land-based exercise for children with post-COVID-19 condition (postCOVIDkids)&#x2014;protocol for a randomized controlled trial. Ogonowska-Slodownik A, Labecka MK, Kaczmarczyk K, et al.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659109/ Int J Environ Res Public Health. 2022;19:14476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9659109</ArticleId><ArticleId IdType="pubmed">36361362</ArticleId></ArticleIdList></Reference><Reference><Citation>Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study. Oliver-Mas S, Delgado-Alonso C, Delgado-&#xc1;lvarez A, et al. Brain Commun. 2023;5:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10116605</ArticleId><ArticleId IdType="pubmed">37091591</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of a home-based inspiratory muscular training programme on functional capacity in patients with chronic COVID-19 after a hospital discharge: protocol for a randomised control trial (InsCOVID trial) Palau P, Dom&#xed;nguez E, Sastre C, et al. BMJ Open Respir Res. 2022;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9257865</ArticleId><ArticleId IdType="pubmed">35790316</ArticleId></ArticleIdList></Reference><Reference><Citation>An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial. Philip KE, Owles H, McVey S, et al. Lancet Respir Med. 2022;10:851&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9045747</ArticleId><ArticleId IdType="pubmed">35489367</ArticleId></ArticleIdList></Reference><Reference><Citation>Effectiveness of a telerehabilitation intervention using ReCOVery APP of long COVID patients: a randomized, 3-month follow-up clinical trial. [ Jun; 2024 ];Samper-Pardo M, Le&#xf3;n-Herrera S, Oliv&#xe1;n-Bl&#xe1;zquez B, M&#xe9;ndez-L&#xf3;pez F, Dom&#xed;nguez-Garc&#xed;a M, S&#xe1;nchez-Recio R. Sci Rep. 2023 13:7943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10187508</ArticleId><ArticleId IdType="pubmed">37193738</ArticleId></ArticleIdList></Reference><Reference><Citation>Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC) Santana K, Fran&#xe7;a E, Sato J, et al. Brain Stimul. 2023;16:100&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9867562</ArticleId><ArticleId IdType="pubmed">36693536</ArticleId></ArticleIdList></Reference><Reference><Citation>Effects of l-arginine plus vitamin C supplementation on physical performance, endothelial function, and persistent fatigue in adults with long COVID: a single-blind randomized controlled trial. Tosato M, Calvani R, Picca A, et al. Nutrients. 2022;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9738241</ArticleId><ArticleId IdType="pubmed">36501014</ArticleId></ArticleIdList></Reference><Reference><Citation>Randomized controlled trial of home-based vs. hospital-based pulmonary rehabilitation in post COVID-19 patients. Vallier JM, Simon C, Bronstein A, Dumont M, Jobic A, Paleiron N, Mely L. Eur J Phys Rehabil Med. 2023;59:103&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10035444</ArticleId><ArticleId IdType="pubmed">36700245</ArticleId></ArticleIdList></Reference><Reference><Citation>Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABA(B)-ergic activity and cortical plasticity in long COVID-19 syndrome. Versace V, Ortelli P, Dezi S, et al. Clin Neurophysiol. 2023;145:81&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9650483</ArticleId><ArticleId IdType="pubmed">36455453</ArticleId></ArticleIdList></Reference><Reference><Citation>Use of platelet-rich plasma for COVID-19 related olfactory loss, a randomized controlled trial. Yan CH, Jang SS, Lin HF, Ma Y, Khanwalker AR, Thai A, Patel ZM. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877663/ Int Forum Allergy Rhinol. 2022;13:989&#x2013;997.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9877663</ArticleId><ArticleId IdType="pubmed">36507615</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Zilberman-Itskovich S, Catalogna M, Sasson E, et al. Sci Rep. 2022;12:11252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9276805</ArticleId><ArticleId IdType="pubmed">35821512</ArticleId></ArticleIdList></Reference><Reference><Citation>Female gender is associated with long COVID syndrome: a prospective cohort study. Bai F, Tomasoni D, Falcinella C, et al. Clin Microbiol Infect. 2022;28:611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence and risk factor for long COVID in children and adolescents: a meta-analysis and systematic review. Zheng YB, Zeng N, Yuan K, et al. J Infect Public Health. 2023;16:660&#x2013;672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9990879</ArticleId><ArticleId IdType="pubmed">36931142</ArticleId></ArticleIdList></Reference><Reference><Citation>Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Stefano GB. Med Sci Monit. 2021;27:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7924007</ArticleId><ArticleId IdType="pubmed">33633106</ArticleId></ArticleIdList></Reference><Reference><Citation>Encephalitis lethargica: last century's long haulers? Kroker K. CMAJ. 2021;193:0&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8476214</ArticleId><ArticleId IdType="pubmed">34544789</ArticleId></ArticleIdList></Reference><Reference><Citation>Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. Sukocheva OA, Maksoud R, Beeraka NM, et al. J Adv Res. 2022;40:179&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619886</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Chronic fatigue syndrome. Cleare AJ, Reid S, Chalder T, Hotopf M, Wessely S. https://pubmed.ncbi.nlm.nih.gov/26415100/ BMJ Clin Evid. 2015;2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4585442</ArticleId><ArticleId IdType="pubmed">26415100</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-viral anosmia (loss of sensation of smell) did not begin with COVID-19! Dicpinigaitis PV. Lung. 2021;199:237&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8067782</ArticleId><ArticleId IdType="pubmed">33893845</ArticleId></ArticleIdList></Reference><Reference><Citation>The prevalence and long-term health effects of long covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. O'Mahoney LL, Routen A, Gillies C, et al. EClinicalMedicine. 2023;55:101762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic review of registered trials. Hawke LD, Nguyen AT, Ski CF, Thompson DR, Ma C, Castle D. Psychol Med. 2022;52:2426&#x2013;2440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9300978</ArticleId><ArticleId IdType="pubmed">35768406</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>